Table 1 Association of Cbx7 mRNA level and clinicopathological features of colon cancer patients

Age (years)

≤62

42

2.69 (1.07-4.61) ^b

2.42 (1.31-4.88)

>62

55

1.38 (0.44-3.37)

1.72 (0.98-4.43)

Sex

Male

49

2.04 (0.74-4.54)

1.77 (0.97-4.00)

Female

48

1.60 (0.90-3.40)

2.22 (1.31-5.29)

Location

Ascending/Transverse

42

1.94 (1.05-4.52)

1.70 (1.27-3.27)

Descending/Sigmoid

37

1.90 (0.72-4.61)

1.94 (1.04-6.26)

Undefined

18

1.29 (0.61-2.75)

2.42 (1.20-7.74)

Differentiation

Poor

24

1.60 (0.89-3.59)

1.60 (1.31-3.54)

Moderate/Well

70

2.02 (0.76-4.59)

2.22 (0.949-6.05)

Vascular invasion

Absent

69

1.95 (0.79-4.48)

1.94 (1.27-5.25)

Present

26

1.74 (0.69-4.13)

1.90 (1.13-4.71)

pTNM

I&II

39

2.06 (1.01-4.54)

1.94 (0.66-5.41)

III&IV

58

1.63 (0.69-3.92)

1.90 (1.30-4.66)

Invasion

T1 ~ 2

5

5.77 (4.48-8.25)

1.31 (0.30-3.09)

T3

51

1.40 (0.38-3.73)

2.39 (0.94-5.83)

T4

41

1.83 (0.96-3.81)

1.82 (1.31-3.39)

Lymph metastasis

Negative

50

2.54 (1.07-4.57 ) ^b

1.77 (1.18-4.63)

Positive

47

1.29 (0.24-2.94)

2.22 (1.12-4.85)

Distant metastasis

Negative

69

2.04 (0.96-4.27)

1.94 (1.08-4.95)

Positive

29

1.31 (0.42-4.56)

1.97 (1.22-5.15)

Post-operative therapy

No

48

1.93 (0.75-3.77)

1.75 (1.03-5.03)

Yes

49

1.64 (0.94-4.48)

2.22 (1.27-4.00)